Link copied to clipboard!
Thumbay launches UAE’s first academic longevity medicine programs with Geneva College, training healthcare professionals for prevention-focused care.

Thumbay to Launch UAE’s First Academic Programs in Longevity Medicine with Switzerland’s Geneva College of Longevity Science

IMT News Desk
IMT News Desk
· 3 min read

Thumbay Group has signed a Memorandum of Understanding (MoU) with Switzerland’s Geneva College of Longevity Science (GCLS), becoming the first private medical university in the UAE to introduce structured academic programmes in Longevity Medicine, Healthy Ageing, Preventive Healthcare and Precision Health through the newly established Thumbay Institute of Longevity Medicine. The initiative supports the UAE’s ambition to emerge as a global hub for advanced healthcare, preventive medicine and medical innovation, while positioning the UAE and wider GCC region as emerging leaders in longevity science.

Under the collaboration, the Thumbay Institute of Longevity Medicine will launch six internationally developed professional certificate programmes in academic partnership with GCLS, delivered in a hybrid format over three months with an initial intake of around 100 participants per programme. The courses include the Thumbay Professional Certificate in Clinical Longevity Medicine, Longevity Physiotherapy, Longevity Nutrition, Longevity Fitness, Peptide Medicine and Artificial Intelligence in Healthcare, reflecting the breadth of skills required for next-generation, prevention-focused care.

The partnership builds on findings from GCLS’s 2026 Global Longevity Physician Survey, which reported rising worldwide demand for longevity medicine: 99% of longevity physicians noted growing patient interest, with 44% seeing demand rise by more than 50% in just three years. The survey also found that 83% of respondents expect healthcare to shift decisively toward prevention, while 76% believe major lifespan extension could become realistic within the next 20 years, underscoring the urgency of formal education and training in the field.

Commenting on the MoU, Dr. Thumbay Moideen, Founder President, Thumbay Group, said: “By joining hands with the Geneva College of Longevity Science, we are bringing world-class Swiss academic standards to the UAE and giving healthcare professionals across the Gulf the training this new era demands. Our vision is to transform Gulf Medical University from the No. 1 private medical university in the Gulf into the world’s leading medical university.”

Dr. Dominik Thor, President, Geneva College of Longevity Science, added: “Longevity medicine is becoming an essential component of modern healthcare, but the field urgently needs education, clinical standards and credible training infrastructure. Through partnerships with leading universities, GCLS is helping to establish the academic foundations globally, and Gulf Medical University is the ideal partner to build that infrastructure in the Middle East.”

The MoU outlines a phased collaboration starting with education and professional development, with the scope to expand into co-branded conferences, workshops, symposiums and other joint activities as the partnership evolves. All programmes will be fully compliant with relevant health authorities.

Read Next

Apollo Hospitals launches ‘Always Open, Always Here’
News
August 18, 2026

Apollo Hospitals launches ‘Always Open, Always Here’

A first-of-its-kind initiative extending consultations, diagnostics, preventive health checks and scheduled care to Sundays across Apollo Hospitals.  Apollo Hospitals announced the launch of ‘Always Open. Always Here.’, a first-of-its-kind initiative that makes routine and planned healthcare services available across all seven days of the week, including Sundays.  Apollo’s emergency, critical care and inpatient services have always been available 24×7. The new initiative extends […]
Article by: IMT News Desk
Lissun raises Rs. 48 Crore to scale child development units
News
August 18, 2026

Lissun raises Rs. 48 Crore to scale child development units

Lissun raises INR 48 Crore in Series A led by Colossa Ventures along with participation from Physis Capital and RPSG Capital Ventures, to scale child development ecosystem. Lissun, a single specialty health-tech company focused on children with special needs and developmental delay, today announced the successful closure of its Series A funding round of INR […]
Article by: IMT News Desk
Can genetic testing help us make better health decisions?
Expert's Corner
August 18, 2026

Can genetic testing help us make better health decisions?

Mr. Rahul Ranganathan, Chief Executive Officer at NuGenomics, explains the concept of genetic testing and how it helps people make better health decisions based on their own biology.  India has witnessed a huge transformation over the years in how diagnoses and treatments for various diseases are made. In recent years, with the advancement in technology, the […]
Article by: IMT News Desk
Hearzap Acquires Amplifon India
News
August 18, 2026

Hearzap Acquires Amplifon India

Strengthening its position as a leading force in India’s organized hearing healthcare sector. Hearzap today announced the successful completion of its acquisition of Amplifon India’s hearing healthcare business, following the definitive agreement announced in May 2026, marking one of the most significant developments in India’s organised hearing healthcare sector. Supported by its investor 360 ONE Asset […]
Article by: IMT News Desk